Catherine Lequeu
Overview
Explore the profile of Catherine Lequeu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Croisier D, Benoit M, Durand D, Lequeu C, Piroth L, Portier H, et al.
Scand J Infect Dis
. 2007 Mar;
39(2):115-21.
PMID: 17366027
We investigated the efficacy of 2 formulations of Augmentin on experimental pneumonia due to Haemophilus influenzae (HI) in rabbits. Two strains were used (H128 and 401285) with amoxicillin/clavulanic acid MICs...
2.
Charles P, Etienne M, Croisier D, Piroth L, Lequeu C, Pugin J, et al.
Crit Care Med
. 2005 May;
33(5):1029-35.
PMID: 15891332
Objective: Streptococcus pneumoniae is a leading cause of community-acquired pneumonia and is responsible for early-onset ventilator-associated pneumonia as well. In intensive care units, community-acquired pneumonia is still associated with a...
3.
Charles P, Martin L, Etienne M, Croisier D, Piroth L, Lequeu C, et al.
Intensive Care Med
. 2004 Nov;
30(12):2263-70.
PMID: 15536527
Objective: Ventilatory strategies combining low tidal volume (V(T)) with positive end-expiratory pressure (PEEP) are considered to be lung protective. The influence of the PEEP level was investigated on bacteriology and...
4.
Etienne M, Croisier D, Charles P, Lequeu C, Piroth L, Portier H, et al.
J Infect Dis
. 2004 Sep;
190(8):1472-5.
PMID: 15378440
Background: We measured the effect of low-level fluoroquinolone resistance in Streptococcus pneumoniae on the development of high-level resistance within the context of the mutant selection window. Methods: Rabbits infected with...
5.
Croisier D, Etienne M, Piroth L, Bergoin E, Lequeu C, Portier H, et al.
J Antimicrob Chemother
. 2004 Aug;
54(3):640-7.
PMID: 15317743
Objectives: To investigate the impact of low levels of fluoroquinolone resistance on the emergence of resistant mutants, we examined the mutant selection window (MSW) hypothesis in experimental pneumonia in rabbits...
6.
Croisier D, Etienne M, Bergoin E, Charles P, Lequeu C, Piroth L, et al.
Antimicrob Agents Chemother
. 2004 Apr;
48(5):1699-707.
PMID: 15105123
For some pneumococci the fluoroquinolone MICs are low but the mutant prevention concentrations (MPCs) are high; this difference defines in vitro the mutant selection window (MSW). We investigated in vivo...
7.
Charles P, Piroth L, Desbiolles N, Lequeu C, Martin L, Portier H, et al.
Crit Care Med
. 2002 Oct;
30(10):2278-83.
PMID: 12394956
Objective: Despite the high rate of therapeutic failures in ventilator-associated pneumonia, up to now there has been no animal model specifically designed for antimicrobial evaluation. A rabbit model of ventilator-associated...
8.
Croisier D, Chavanet P, Lequeu C, Ahanou A, Nierlich A, Neuwirth C, et al.
J Antimicrob Chemother
. 2002 Sep;
50(3):349-60.
PMID: 12205059
Newer fluoroquinolones, such as levofloxacin, have shown an enhanced in vitro and in vivo activity against penicillin-resistant Streptococcus pneumoniae infections. The frequency of S. pneumoniae with reduced susceptibility to quinolones,...